4basebio UK Societas(GB:4BB)
GBXÂ 525.000.00 (0.00%)
GB:4BB
4basebio UK Societas financials statements
GBXÂ 525.00
At close:0.00 (0.00%)
Want to see GB:4BB full AI Analyst Report?
4basebio UK Societas (4BB) Ratios
8 Followers
4basebio UK Societas Ratios
GB:4BB's free cash flow for Q2 2026 was £-9.33M. For the 2026 fiscal year, GB:4BB's free cash flow was decreased by £-1.08M and operating cash flow was £-8.25M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.31 | 11.30 | 2.21 | 3.88 | 6.99 |
| Quick Ratio | 7.07 | 11.18 | 2.06 | 3.80 | 6.89 |
| Cash Ratio | 6.30 | 10.60 | 1.35 | 2.87 | 6.29 |
| Solvency Ratio | -0.81 | -0.62 | -0.56 | -1.03 | -0.97 |
| Operating Cash Flow Ratio | -5.22 | -3.29 | -2.71 | -3.10 | -1.80 |
| Short-Term Operating Cash Flow Coverage | -87.28 | -73.09 | -23.49 | -14.65 | -7.70 |
| Net Current Asset Value | £ 1.23M | £ 18.54M | £ -7.39M | £ 1.33M | £ 7.63M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.56 | 0.34 | 0.88 | 0.29 | 0.12 |
| Debt-to-Equity Ratio | 1.63 | 0.58 | -21.25 | 0.47 | 0.15 |
| Debt-to-Capital Ratio | 0.62 | 0.37 | 1.05 | 0.32 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.61 | 0.35 | 1.06 | 0.25 | 0.07 |
| Financial Leverage Ratio | 2.92 | 1.70 | -24.23 | 1.64 | 1.26 |
| Debt Service Coverage Ratio | -14.09 | -11.84 | -11.78 | -11.29 | -5.97 |
| Interest Coverage Ratio | -18.86 | -16.01 | -26.66 | -65.62 | -31.21 |
| Debt to Market Cap | 0.17 | 0.09 | 0.11 | 0.03 | 0.02 |
| Interest Debt Per Share | 1.12 | 1.22 | 0.87 | 0.28 | 0.15 |
| Net Debt to EBITDA | 0.08 | 1.77 | -1.01 | 0.19 | 2.44 |
| Profitability Margins | |||||
| Gross Profit Margin | 32.37% | 67.52% | 67.19% | 89.18% | 79.59% |
| EBIT Margin | -988.01% | -1275.67% | -1591.30% | -2179.10% | -1043.49% |
| EBITDA Margin | -920.38% | -1175.67% | -1451.19% | -2018.28% | -948.82% |
| Operating Profit Margin | -988.01% | -1290.68% | -1591.30% | -2179.10% | -1043.49% |
| Pretax Profit Margin | -1039.75% | -1356.27% | -1650.99% | -2212.31% | -1076.92% |
| Net Profit Margin | -998.52% | -1321.86% | -1514.82% | -1921.64% | -957.10% |
| Continuous Operations Profit Margin | -998.52% | -1321.86% | -1514.82% | -1921.64% | -957.10% |
| Net Income Per EBT | 96.03% | 97.46% | 91.75% | 86.86% | 88.87% |
| EBT Per EBIT | 105.24% | 105.08% | 103.75% | 101.52% | 103.20% |
| Return on Assets (ROA) | -57.21% | -27.57% | -64.29% | -44.06% | -22.00% |
| Return on Equity (ROE) | -167.19% | -46.75% | 1557.93% | -72.33% | -27.66% |
| Return on Capital Employed (ROCE) | -62.60% | -29.04% | -83.48% | -57.42% | -26.76% |
| Return on Invested Capital (ROIC) | -59.74% | -28.18% | -73.61% | -47.92% | -23.03% |
| Return on Tangible Assets | -68.37% | -29.90% | -82.84% | -53.84% | -24.09% |
| Earnings Yield | -17.73% | -7.77% | -9.15% | -5.89% | -4.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.86 | 3.30 | 4.73 | 4.96 | 7.35 |
| Payables Turnover | 1.09 | 0.18 | 0.24 | 0.06 | 0.20 |
| Inventory Turnover | 1.74 | 0.81 | 0.50 | 0.22 | 0.44 |
| Fixed Asset Turnover | 0.42 | 0.22 | 0.12 | 0.07 | 0.12 |
| Asset Turnover | 0.06 | 0.02 | 0.04 | 0.02 | 0.02 |
| Working Capital Turnover Ratio | 0.07 | 0.05 | 0.14 | 0.04 | 0.03 |
| Cash Conversion Cycle | -63.61 | -1479.39 | -718.78 | -4419.73 | -992.43 |
| Days of Sales Outstanding | 62.31 | 110.71 | 77.18 | 73.54 | 49.67 |
| Days of Inventory Outstanding | 209.44 | 450.53 | 730.00 | 1673.97 | 825.22 |
| Days of Payables Outstanding | 335.35 | 2040.63 | 1525.96 | 6167.24 | 1867.32 |
| Operating Cycle | 271.74 | 561.24 | 807.18 | 1747.51 | 874.89 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.95 | -0.82 | -0.50 | -0.38 | -0.22 |
| Free Cash Flow Per Share | -0.98 | -0.94 | -0.62 | -0.54 | -0.35 |
| Dividend Paid and CapEx Coverage Ratio | -32.21 | -6.84 | -4.15 | -2.42 | -1.81 |
| Capital Expenditure Coverage Ratio | -32.21 | -6.84 | -4.15 | -2.42 | -1.81 |
| Operating Cash Flow Coverage Ratio | -0.89 | -0.71 | -0.59 | -1.40 | -1.56 |
| Operating Cash Flow to Sales Ratio | -8.71 | -11.52 | -12.21 | -17.55 | -8.11 |
| Free Cash Flow Yield | -15.95% | -7.76% | -9.15% | -7.60% | -5.61% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.64 | -12.87 | -10.93 | -16.98 | -23.42 |
| Price-to-Sales (P/S) Ratio | 56.33 | 170.11 | 165.56 | 326.32 | 224.12 |
| Price-to-Book (P/B) Ratio | 9.43 | 6.02 | -170.27 | 12.28 | 6.48 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.27 | -12.89 | -10.92 | -13.16 | -17.82 |
| Price-to-Operating Cash Flow Ratio | -6.47 | -14.77 | -13.56 | -18.59 | -27.65 |
| Price-to-Earnings Growth (PEG) Ratio | -0.35 | -0.25 | -0.23 | -0.28 | -0.07 |
| Enterprise Value Multiple | -6.04 | -12.70 | -12.41 | -15.98 | -21.18 |
| Enterprise Value | 94.07M | 139.32M | 91.16M | 86.45M | 67.92M |
| EV to EBITDA | -6.04 | -12.70 | -12.41 | -15.98 | -21.18 |
| EV to Sales | 55.57 | 149.33 | 180.16 | 322.59 | 200.96 |
| EV to Free Cash Flow | -6.19 | -11.31 | -11.89 | -13.01 | -15.97 |
| EV to Operating Cash Flow | -6.38 | -12.97 | -14.76 | -18.38 | -24.79 |
| Tangible Book Value Per Share | 0.34 | 1.75 | -0.26 | 0.41 | 0.85 |
| Shareholders’ Equity Per Share | 0.65 | 2.01 | -0.04 | 0.58 | 0.95 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.04 | 0.03 | 0.08 | 0.13 | 0.11 |
| Revenue Per Share | 0.11 | 0.07 | 0.04 | 0.02 | 0.03 |
| Net Income Per Share | -1.09 | -0.94 | -0.62 | -0.42 | -0.26 |
| Tax Burden | 0.96 | 0.97 | 0.92 | 0.87 | 0.89 |
| Interest Burden | 1.05 | 1.06 | 1.04 | 1.02 | 1.03 |
| Research & Development to Revenue | 3.03 | 5.02 | 7.04 | 7.76 | 4.80 |
| SG&A to Revenue | 1.33 | 1.89 | 2.49 | 10.12 | 5.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.48 | 0.24 |
| Income Quality | 0.87 | 0.87 | 0.81 | 0.91 | 0.85 |
Currency in GBP
